Medtronic plc, a global leader in healthcare technology, is partnering with professional tennis player Alexander Zverev and his foundation to elevate global awareness of type 1 diabetes.  

Through this advocacy partnership, Zverev and Medtronic will amplify voices from the type 1 diabetes community and shine a light on the strength, resilience, and limitless potential of those overcoming the daily challenges of the disease — proving that diabetes doesn’t have to hold anyone back from living life to the fullest. By sharing his personal journey and defying expectations on and off the court, Zverev hopes to empower others living with diabetes to see what’s possible.

Diagnosed with type 1 diabetes at just four years old, Zverev spent years hiding his condition, fearing judgment. But now, he’s turning his story into a source of strength and inspiration. 

“Becoming a professional tennis player was always my dream,” Zverev shared. “Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That’s why I’m partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want.”

At the heart of this partnership is a shared belief: managing diabetes should never stand in the way of living fully. Inspired by the desire to introduce more stability and predictability for people with diabetes, Medtronic Diabetes delivers cutting-edge technology — including automated insulin delivery systems — designed to reduce the daily burden of diabetes and help people stay in range^*, sleep through the night, and live life on their terms.  

“Alexander is a powerful example of constantly pushing the limits of what’s possible and inspiring millions along the way,” said Que Dallara, EVP and president of Medtronic Diabetes. “This is closely aligned with our Mission to make diabetes more predictable so everyone can embrace life to the fullest.”

Zverev defied early expectations to become one of the world’s best tennis players, reaching a career-high ATP ranking of No. 2, winning Olympic gold, and claiming two ATP Finals titles — all while living with type 1 diabetes. From a young age, he was told his condition would limit him, but he refused to accept that: “I was upset that these limits were placed on me as a kid — I didn’t think it was fair, and I don’t want any child to believe that about themselves,” Zverev shared.

In 2022, Zverev teamed up with his brother Mischa and parents, Irina and Alexander Zverev Sr., to launch the Alexander Zverev Foundation, which supports children with type 1 diabetes around the world. The foundation provides access to essential diabetes care — including insulin and other medication — and organizes activities like tennis and ski camps for children to promote healthy, active lifestyles. Together, Medtronic and Zverev are sending a clear message: diabetes may be part of your story — but it doesn’t write the ending.

About the Diabetes Business at Medtronic  

Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced diabetes technology and always-on support when and how they need it. We've pioneered first-of-its-kind innovations for over 40 years and are committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. 

About Medtronic 

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 
*Refers to SmartGuard™ technology. Individual results may vary.

Contacts:
Andrew Crawford 
Global Communications
+41 79 3781932

Ryan Weispfenning
Investor Relations
+1-763-505-4626